Qualification of Drivers; Exemption Applications; Implantable Cardioverter Defibrillators, 30007 [2020-10689]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 97 / Tuesday, May 19, 2020 / Notices
dyspnea, collapse, or congestive cardiac
failure.
In addition to the regulations, FMCSA
has published advisory criteria 1 to
assist medical examiners in determining
whether drivers with certain medical
conditions are qualified to operate a
CMV in interstate commerce. The
advisory criteria states that ICDs are
disqualifying due to risk of syncope.
III. Qualifications of Applicant
Kenneth Randolph
Mr. Kenneth Randolph is a CMV
driver in Florida. A January 6, 2020,
letter from his cardiologist reports that
his ICD was implanted in March of
2010, has never deployed, that he is
asymptomatic, and that his underlying
heart condition is stable.
Request for Comments
In accordance with 49 U.S.C. 31136(e)
and 31315(b), FMCSA requests public
comment from all interested persons on
the exemption petition described in this
notice. We will consider all comments
received before the close of business on
the closing date indicated under the
DATES section of the notice.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2020–10690 Filed 5–18–20; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[Docket No. FMCSA–2020–0087]
Qualification of Drivers; Exemption
Applications; Implantable Cardioverter
Defibrillators
Federal Motor Carrier Safety
Administration (FMCSA), DOT.
ACTION: Notice of correction; extension
of comment period.
AGENCY:
FMCSA corrects the State of
domicile for one individual listed in its
April 15, 2020, notice requesting
comments on the receipt of applications
from five individuals for an exemption
from the prohibition in the Federal
Motor Carrier Safety Regulations
(FMCSRs) against operation of a
commercial motor vehicle (CMV) by
persons with a current clinical diagnosis
SUMMARY:
1 These criteria may be found in 49 CFR part 391,
APPENDIX A TO PART 391—MEDICAL
ADVISORY CRITERIA, section D. Cardiovascular:
§ 391.41(b)(4), paragraph 4, which is available on
the internet at https://www.gpo.gov/fdsys/pkg/CFR2015-title49-vol5/pdf/CFR-2015-title49-vol5part391-appA.pdf.
VerDate Sep<11>2014
17:57 May 18, 2020
Jkt 250001
of myocardial infarction, angina
pectoris, coronary insufficiency,
thrombosis, or any other cardiovascular
disease of a variety known to be
accompanied by syncope (transient loss
of consciousness), dyspnea (shortness of
breath), collapse, or congestive heart
failure. The Agency also extends the
public comment period for that notice.
DATES: This correction is effective May
19, 2020. The comment period for the
notice published April 15, 2020, at 85
FR 21061, is extended by 30 days.
Comments must be received on or
before June 15, 2020.
ADDRESSES: You may submit comments
identified by the Federal Docket
Management System (FDMS) Docket ID
FMCSA–2020–0087 using any of the
following methods:
• Federal eRulemaking Portal: Go to
https://www.regulations.gov/
docket?D=FMCSA-2020-0087. Follow
the online instructions for submitting
comments.
• Mail: Docket Management Facility;
U.S. Department of Transportation, 1200
New Jersey Avenue SE, West Building
Ground Floor, Room W12–140,
Washington, DC 20590–0001.
• Hand Delivery: West Building
Ground Floor, Room W12–140, 1200
New Jersey Avenue SE, Washington,
DC, between 9 a.m. and 5 p.m., ET,
Monday through Friday, except Federal
Holidays.
• Fax: (202) 493–2251.
To avoid duplication, please use only
one of these four methods. See the
‘‘Public Participation’’ portion of the
SUPPLEMENTARY INFORMATION section for
instructions on submitting comments.
FOR FURTHER INFORMATION CONTACT: Ms.
Christine A. Hydock, Chief, Medical
Programs Division, (202) 366–4001,
fmcsamedical@dot.gov, FMCSA,
Department of Transportation, 1200
New Jersey Avenue SE, Room W64–224,
Washington, DC 20590–0001. Office
hours are from 8:30 a.m. to 5 p.m., ET,
Monday through Friday, except Federal
holidays. If you have questions
regarding viewing or submitting
material to the docket, contact Docket
Operations, (202) 366–9826.
SUPPLEMENTARY INFORMATION: On April
15, 2020, (85 FR 21061), FMCSA
published a notice regarding five
individuals requesting an exemption
from the physical qualification standard
found in § 391.41(b)(4), which states
that a person is physically qualified to
drive a CMV if that person has no
current clinical diagnosis of myocardial
infarction, angina pectoris, coronary
insufficiency, thrombosis, or any other
cardiovascular disease of a variety
known to be accompanied by syncope,
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
30007
dyspnea, collapse, or congestive cardiac
failure. The notice referenced, in error,
Minnesota as the State of domicile for
the applicant, Theodore J. Engelke. Mr.
Engelke’s correct State of domicile is
Wisconsin.
In addition, FMCSA extends the
comment period to ensure that
interested parties have sufficient time to
review and comment on the exemption
applications.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2020–10689 Filed 5–18–20; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[Docket No. FMCSA–2020–0047]
Qualification of Drivers; Exemption
Applications; Epilepsy and Seizure
Disorders
Federal Motor Carrier Safety
Administration (FMCSA), DOT.
ACTION: Notice of applications for
exemption; request for comments.
AGENCY:
FMCSA announces receipt of
applications from 10 individuals for an
exemption from the prohibition in the
Federal Motor Carrier Safety
Regulations (FMCSRs) against persons
with a clinical diagnosis of epilepsy or
any other condition that is likely to
cause a loss of consciousness or any loss
of ability to control a commercial motor
vehicle (CMV) to drive in interstate
commerce. If granted, the exemptions
would enable these individuals who
have had one or more seizures and are
taking anti-seizure medication to
operate CMVs in interstate commerce.
DATES: Comments must be received on
or before June 18, 2020.
ADDRESSES: You may submit comments
identified by the Federal Docket
Operations Docket No. FMCSA–2020–
0047 using any of the following
methods:
• Federal eRulemaking Portal: Go to
https://www.regulations.gov/docket
?D=FMCSA-2020-0047. Follow the
online instructions for submitting
comments.
• Mail: Docket Operations; U.S.
Department of Transportation, 1200
New Jersey Avenue SE, West Building
Ground Floor, Room W12–140,
Washington, DC 20590–0001.
• Hand Delivery: West Building
Ground Floor, Room W12–140, 1200
New Jersey Avenue SE, Washington,
DC, between 9 a.m. and 5 p.m., ET,
SUMMARY:
E:\FR\FM\19MYN1.SGM
19MYN1
]]>Agencies
[Federal Register Volume 85, Number 97 (Tuesday, May 19, 2020)]
[Notices]
[Page 30007]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-10689]
-----------------------------------------------------------------------
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration
[Docket No. FMCSA-2020-0087]
Qualification of Drivers; Exemption Applications; Implantable
Cardioverter Defibrillators
AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.
ACTION: Notice of correction; extension of comment period.
-----------------------------------------------------------------------
SUMMARY: FMCSA corrects the State of domicile for one individual listed
in its April 15, 2020, notice requesting comments on the receipt of
applications from five individuals for an exemption from the
prohibition in the Federal Motor Carrier Safety Regulations (FMCSRs)
against operation of a commercial motor vehicle (CMV) by persons with a
current clinical diagnosis of myocardial infarction, angina pectoris,
coronary insufficiency, thrombosis, or any other cardiovascular disease
of a variety known to be accompanied by syncope (transient loss of
consciousness), dyspnea (shortness of breath), collapse, or congestive
heart failure. The Agency also extends the public comment period for
that notice.
DATES: This correction is effective May 19, 2020. The comment period
for the notice published April 15, 2020, at 85 FR 21061, is extended by
30 days. Comments must be received on or before June 15, 2020.
ADDRESSES: You may submit comments identified by the Federal Docket
Management System (FDMS) Docket ID FMCSA-2020-0087 using any of the
following methods:
Federal eRulemaking Portal: Go to https://www.regulations.gov/docket?D=FMCSA-2020-0087. Follow the online
instructions for submitting comments.
Mail: Docket Management Facility; U.S. Department of
Transportation, 1200 New Jersey Avenue SE, West Building Ground Floor,
Room W12-140, Washington, DC 20590-0001.
Hand Delivery: West Building Ground Floor, Room W12-140,
1200 New Jersey Avenue SE, Washington, DC, between 9 a.m. and 5 p.m.,
ET, Monday through Friday, except Federal Holidays.
Fax: (202) 493-2251.
To avoid duplication, please use only one of these four methods.
See the ``Public Participation'' portion of the SUPPLEMENTARY
INFORMATION section for instructions on submitting comments.
FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief,
Medical Programs Division, (202) 366-4001, [email protected], FMCSA,
Department of Transportation, 1200 New Jersey Avenue SE, Room W64-224,
Washington, DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m.,
ET, Monday through Friday, except Federal holidays. If you have
questions regarding viewing or submitting material to the docket,
contact Docket Operations, (202) 366-9826.
SUPPLEMENTARY INFORMATION: On April 15, 2020, (85 FR 21061), FMCSA
published a notice regarding five individuals requesting an exemption
from the physical qualification standard found in Sec. 391.41(b)(4),
which states that a person is physically qualified to drive a CMV if
that person has no current clinical diagnosis of myocardial infarction,
angina pectoris, coronary insufficiency, thrombosis, or any other
cardiovascular disease of a variety known to be accompanied by syncope,
dyspnea, collapse, or congestive cardiac failure. The notice
referenced, in error, Minnesota as the State of domicile for the
applicant, Theodore J. Engelke. Mr. Engelke's correct State of domicile
is Wisconsin.
In addition, FMCSA extends the comment period to ensure that
interested parties have sufficient time to review and comment on the
exemption applications.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2020-10689 Filed 5-18-20; 8:45 am]
BILLING CODE 4910-EX-P
